NASDAQ:UTHR

United Therapeutics Stock Insider Trading

etoro logo Buy UTHR
*Your capital is at risk
$535.57
-11.49 (-2.10%)
At Close: Jul 13, 2026

United Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -87.09. In total, the insiders bought 161.34K and sold 66.07K UTHR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-87.09
Buy 161.34K shares
Sell 66.07K shares
30% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Apr 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -87.09.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 524
Value: $831.4K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 970
Value: $525.2K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 600
Value: $324.2K
Jul 10, 2026
Buy
Common Stock
M-Exempt
Rothblatt Martine A
Chairperson & CEO
CEO / President 9 500
Value: $1.29M
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 676
Value: $367.3K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 364
Value: $198.2K
Jul 10, 2026
Buy
Stock Option
M-Exempt
Rothblatt Martine A
Chairperson & CEO
CEO / President 9 500
Value: $1.29M
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 400
Value: $219.4K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 80
Value: $44.3K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 578
Value: $863.4K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 438
Value: $785.8K
Jul 10, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 870
Value: $1.01M
Jul 10, 2026
Sell
Common Stock
S-Sale
Malcolm Jan
Director
Director 325
Value: $178.9K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Patusky Christopher
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Restricted Stock Unit
M-Exempt
Sullivan Louis W
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Giltner Richard
Director
Director 1 310
Value: $723.7K
Jul 09, 2026
Buy
Restricted Stock Units
M-Exempt
Mesa Nilda
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Olian Judy D.
Director
Director 1 310
Value: $723.7K
Jul 09, 2026
Buy
Restricted Stock Unit
M-Exempt
Olian Judy D.
Director
Director 1 310
Value: $723.7K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Sullivan Louis W
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Restricted Stock Units
M-Exempt
Kurzweil Ray
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Mesa Nilda
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Restricted Stock Unit
M-Exempt
Patusky Christopher
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Common Stock
M-Exempt
Kurzweil Ray
Director
Director 650
Value: $359.1K
Jul 09, 2026
Buy
Restricted Stock Unit
M-Exempt
Giltner Richard
Director
Director 1 310
Value: $723.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNITED THERAPEUTICS CORPORATION
United Therapeutics
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE